S&P 500   3,047.69 (-2.20%)
DOW   26,318.15 (-2.37%)
QQQ   210.70 (-2.67%)
AAPL   280.63 (-4.11%)
FB   192.32 (-2.47%)
MSFT   163.33 (-4.02%)
GOOGL   1,344.26 (-3.32%)
AMZN   1,923.92 (-2.81%)
CGC   18.90 (-4.64%)
NVDA   260.44 (-2.69%)
BABA   205.89 (-1.37%)
TSLA   704.51 (-9.54%)
AMD   44.84 (-5.60%)
T   36.52 (-1.59%)
NFLX   381.45 (+0.58%)
BAC   29.62 (-3.30%)
DIS   121.23 (-1.73%)
S&P 500   3,047.69 (-2.20%)
DOW   26,318.15 (-2.37%)
QQQ   210.70 (-2.67%)
AAPL   280.63 (-4.11%)
FB   192.32 (-2.47%)
MSFT   163.33 (-4.02%)
GOOGL   1,344.26 (-3.32%)
AMZN   1,923.92 (-2.81%)
CGC   18.90 (-4.64%)
NVDA   260.44 (-2.69%)
BABA   205.89 (-1.37%)
TSLA   704.51 (-9.54%)
AMD   44.84 (-5.60%)
T   36.52 (-1.59%)
NFLX   381.45 (+0.58%)
BAC   29.62 (-3.30%)
DIS   121.23 (-1.73%)
S&P 500   3,047.69 (-2.20%)
DOW   26,318.15 (-2.37%)
QQQ   210.70 (-2.67%)
AAPL   280.63 (-4.11%)
FB   192.32 (-2.47%)
MSFT   163.33 (-4.02%)
GOOGL   1,344.26 (-3.32%)
AMZN   1,923.92 (-2.81%)
CGC   18.90 (-4.64%)
NVDA   260.44 (-2.69%)
BABA   205.89 (-1.37%)
TSLA   704.51 (-9.54%)
AMD   44.84 (-5.60%)
T   36.52 (-1.59%)
NFLX   381.45 (+0.58%)
BAC   29.62 (-3.30%)
DIS   121.23 (-1.73%)
S&P 500   3,047.69 (-2.20%)
DOW   26,318.15 (-2.37%)
QQQ   210.70 (-2.67%)
AAPL   280.63 (-4.11%)
FB   192.32 (-2.47%)
MSFT   163.33 (-4.02%)
GOOGL   1,344.26 (-3.32%)
AMZN   1,923.92 (-2.81%)
CGC   18.90 (-4.64%)
NVDA   260.44 (-2.69%)
BABA   205.89 (-1.37%)
TSLA   704.51 (-9.54%)
AMD   44.84 (-5.60%)
T   36.52 (-1.59%)
NFLX   381.45 (+0.58%)
BAC   29.62 (-3.30%)
DIS   121.23 (-1.73%)
Log in

Alpine Immune Sciences SEC Filings & 10K Form (NASDAQ:ALPN)

$3.14
-0.06 (-1.88 %)
(As of 02/27/2020 01:42 PM ET)
Today's Range
$3.14
Now: $3.14
$3.14
50-Day Range
$2.90
MA: $3.28
$4.40
52-Week Range
$2.25
Now: $3.14
$8.24
Volume100 shs
Average Volume20,338 shs
Market Capitalization$58.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89

SEC Filings

Alpine Immune Sciences (NASDAQ:ALPN) SEC Filings

DateFilerForm TypeView
02/14/2020
1:48 PM
Alpine Immune Sciences (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
01/27/2020
5:02 PM
Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
5:01 PM
Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
5:00 PM
Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
4:20 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
7:02 PM
Alpine Immune Sciences (Issuer)
SEKHRI PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:02 PM
Alpine Immune Sciences (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:02 PM
Alpine Immune Sciences (Issuer)
Venkatesan Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:01 PM
Alpine Immune Sciences (Issuer)
CONWAY ROBERT E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:01 PM
Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:00 PM
Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:00 PM
Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
3:03 PM
Alpine Immune Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2019
3:24 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
8:02 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
6:32 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
4:04 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
7:00 AM
Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
6:42 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
7:31 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:36 PM
Alpine Immune Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
7:11 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
4:27 PM
Alpine Immune Sciences (Filer)
Form DEFA14A
04/24/2019
4:26 PM
Alpine Immune Sciences (Filer)
Form DEF 14A
04/18/2019
3:31 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
3:29 PM
Alpine Immune Sciences (Filer)
Form PRE 14A
04/05/2019
7:53 AM
Alpine Immune Sciences (Filer)
Form 424B3
04/04/2019
11:17 PM
Alpine Immune Sciences (Filer)
Form EFFECT
04/01/2019
3:16 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2019
2:05 PM
Alpine Immune Sciences (Filer)
Form CT ORDER
03/18/2019
3:50 PM
Alpine Immune Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
3:39 PM
Alpine Immune Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
3:21 PM
Alpine Immune Sciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/18/2019
3:02 PM
Alpine Immune Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2019
7:10 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
12:52 PM
Alpine Immune Sciences (Issuer)
TIGER MANAGEMENT L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:32 PM
Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:02 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2019
2:09 PM
Alpine Immune Sciences (Filer)
Form D
Notice of Exempt Offering of Securities 
01/28/2019
3:46 PM
Alpine Immune Sciences (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G
01/24/2019
4:22 PM
Alpine Immune Sciences (Subject)
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by)
Form SC 13D
01/23/2019
7:48 PM
Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
7:46 PM
Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2019
7:45 PM
Alpine Immune Sciences (Issuer)
Decheng Capital China Life Sciences USD Fund III, L.P. (Reporting)
Decheng Capital Management III , LLC (0001747821) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2019
5:01 PM
Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
4:58 PM
Alpine Immune Sciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
4:20 PM
Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
01/22/2019
8:52 PM
Alpine Immune Sciences (Subject)
Alpine ImmunoSciences, L.P. (Filed by)
Form SC 13D/A
01/22/2019
7:46 PM
Alpine Bioventures, GP, LLC (Reporting)
Alpine Immune Sciences (Issuer)
Alpine ImmunoSciences, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
7:44 PM
Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
7:44 PM
Alpine Immune Sciences (Issuer)
Venkatesan Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
4:14 PM
Alpine Immune Sciences (Issuer)
FHM LIFE SCIENCES VIII, L.L.C. (Reporting)
FHM LIFE SCIENCES VIII, L.P. (Reporting)
Frazier Life Sciences VIII, L.P. (Reporting)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
4:09 PM
Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:16 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
3:19 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:03 PM
Alpine Immune Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:53 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
5:05 AM
Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
8:02 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2018
5:07 AM
Alpine Immune Sciences (Subject)
Flynn James E (Filed by)
Form SC 13D/A
08/09/2018
4:17 PM
Alpine Immune Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
3:37 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
5:34 PM
Alpine Immune Sciences (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
5:30 PM
Alpine Immune Sciences (Issuer)
Litton Mark James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2018
6:32 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2018
3:53 PM
Alpine Immune Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2018
3:01 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:06 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:02 PM
Alpine Immune Sciences (Filer)
Form 424B5
05/14/2018
3:01 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2018
3:07 PM
Alpine Immune Sciences (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2018
3:05 PM
Alpine Immune Sciences (Issuer)
Peetz Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2018
8:00 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2018
6:35 AM
Alpine Immune Sciences (Filer)
Form DEFA14A
04/24/2018
6:31 AM
Alpine Immune Sciences (Filer)
Form DEF 14A
03/28/2018
8:12 AM
Alpine Immune Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2018
7:26 AM
Alpine Immune Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2018
6:05 AM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2018
11:23 AM
Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
01/25/2018
8:23 PM
Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
01/04/2018
4:38 PM
Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:34 PM
Alpine Immune Sciences (Issuer)
SEKHRI PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:21 PM
Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:21 PM
Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:18 PM
Alpine Immune Sciences (Issuer)
CONWAY ROBERT E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:18 PM
Alpine Immune Sciences (Issuer)
Venkatesan Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:16 PM
Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:13 PM
Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2017
3:05 PM
Alpine Immune Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2017
9:31 AM
Alpine Immune Sciences (Filer)
Form CT ORDER
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel